Scynexis (SCYX) Treasury Shares (2013 - 2026)
Scynexis (SCYX) posted Treasury Shares of $3.7 million for Q1 2026, up 40.12% on a QoQ basis from $2.7 million in Q4 2025, and up 8.86% year-over-year from $3.4 million in Q1 2025.
Scynexis (SCYX) Treasury Shares (2013 - 2026) Analysis & Trends
Scynexis' Treasury Shares history runs 12 years deep, the most recent figure standing at $3.7 million for Q1 2026.
- Quarterly Treasury Shares rose 8.86% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 8.86% YoY) and the FY2025 annual result came in at $2.7 million, down 14.63% from the prior year.
- Treasury Shares was $3.7 million for Q1 2026 at Scynexis, up from $2.7 million in the prior quarter.
- Across five years, Treasury Shares topped out at $3.7 million in Q1 2026 and bottomed at $633270.0 in Q4 2022.
- A 5-year average of $2.4 million and a median of $2.7 million in 2025 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares jumped 912.48% — and 2025, when it decreased 14.63%.
- Scynexis' Treasury Shares stood at $633270.0 in 2022, then soared by 197.88% to $1.9 million in 2023, then jumped by 65.42% to $3.1 million in 2024, then decreased by 14.63% to $2.7 million in 2025, then jumped by 40.12% to $3.7 million in 2026.
- Business Quant data shows SCYX's Treasury Shares at $3.7 million in Q1 2026, $2.7 million in Q4 2025, and $2.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.73 Mn |
| Mar 31, 2026 | 3.73 Mn |
| Dec 31, 2025 | 2.66 Mn |
| Dec 31, 2025 | 2.66 Mn |
| Sep 30, 2025 | 2.69 Mn |
| Sep 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 3.12 Mn |
| Dec 31, 2024 | 3.12 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | 3.26 Mn |
| Jun 30, 2024 | 3.26 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Dec 31, 2023 | 1.89 Mn |
| Dec 31, 2023 | 1.89 Mn |